FDA granted accelerated approval to asciminib (Scemblix, Novartis) for Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase previously treated w/ TKIs, and approved asciminib for Ph+ CML in CP with the T315I mutation. accessdata.fda.gov/drugsatfda_doc… #leusm

Starting out ASH with running into our colleague and Leukemia guru Martin S. Tallman, MD Yasmin Abaza Magda Dankowska ASH Northwestern Medicine

Today was one of those days that our #PharmDs went above & beyond to care for our #AML pts. Actually, that happens every day….Thank you Talha K, PharmD, BCOP Magda Dankowska and team for today and all the days I forget to share my 💜 and appreciation. Lurie Cancer Center Northwestern Medicine

HMA/Ven for Patients ≥ 75 year old with AML - real world multi-center analysis. Congrats Yasmin Abaza for all your hard works on this! Jessica Altman, MD Lurie Cancer Center Northwestern Medicine pubmed.ncbi.nlm.nih.gov/38342997/